BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao X, Deng B, Xu XY, Yang SJ, Zhang T, Song YJ, Liu XT, Wang YQ, Cai DY. Glycyrrhizinate reduces portal hypertension in isolated perfused rat livers with chronic hepatitis. World J Gastroenterol 2013; 19(36): 6069-6076 [PMID: 24106408 DOI: 10.3748/wjg.v19.i36.6069] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Zabot GP, Carvalhal GF, Marroni NP, Licks F, Hartmann RM, da Silva VD, Fillmann HS. Glutamine prevents oxidative stress in a model of portal hypertension. World J Gastroenterol 2017; 23(25): 4529-4537 [PMID: 28740341 DOI: 10.3748/wjg.v23.i25.4529] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhao X, Jia H, Yang S, Liu Y, Deng B, Xu X, Zhang T, Zhou H, Zu C, Yin H, Li T, Song Y, Wang Y, Li P, Zou Z, Cai D. Salvianolic Acid B reducing portal hypertension depends on macrophages in isolated portal perfused rat livers with chronic hepatitis. Evid Based Complement Alternat Med 2012;2012:786365. [PMID: 23118797 DOI: 10.1155/2012/786365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
3 Garbuzenko DV. Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis. World J Gastroenterol 2015; 21(20): 6117-6126 [PMID: 26034348 DOI: 10.3748/wjg.v21.i20.6117] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
4 Pun CK, Huang HC, Chang CC, Chuang CL, Yen CH, Hsu SJ, Lee FY, Hou MC, Huang YH. Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats. Int J Mol Sci 2021;22:7662. [PMID: 34299285 DOI: 10.3390/ijms22147662] [Reference Citation Analysis]
5 Garbuzenko DV. [Aspects of pathogenetc pharmacotherapy for portal hypertension in liver cirrhosis]. Ter Arkh. 2016;88:101-108. [PMID: 27135108 DOI: 10.17116/terarkh2016888101-108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhao X, Liu J, Yang S, Chen C, Yin H, Li T, Wang Q, Li X, Lin Y, Cai D. Diammonium glycyrrhizinate alleviates hepatopulmonary syndrome via restoring superoxide dismutase 3 activity in rats. European Journal of Pharmacology 2017;807:144-50. [DOI: 10.1016/j.ejphar.2017.04.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]